Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Cough hypersensitivity syndrome: clinical measurement is the key to progress

Richard D. Turner, Graham H. Bothamley
European Respiratory Journal 2015 45: 1507-1508; DOI: 10.1183/09031936.00212714
Richard D. Turner
Dept of Respiratory Medicine, Homerton University Hospital NHS Foundation Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Richard D. Turner
  • For correspondence: richard.turner@homerton.nhs.uk
Graham H. Bothamley
Dept of Respiratory Medicine, Homerton University Hospital NHS Foundation Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

We call for wider measurement of clinical variables in cough in order to define phenotypes and advance cough research http://ow.ly/JXnIz

To the Editor:

The recent European Respiratory Society (ERS) Task Force Report on chronic cough [1] should be commended for drawing attention to a neglected area of respiratory medicine and discussing controversies surrounding the approach to this common clinical problem. Cough hypersensitivity syndrome is proposed as a new shorthand to refer to patient-reported excessive coughing that otherwise evades clinical explanation [1]. As discussed in the report, cough hypersensitivity syndrome may or may not be associated with other causes of chronic cough, and its peripheral and central mechanisms are only partly understood [1].

The comparison of cough hypersensitivity syndrome with chronic obstructive pulmonary disease (COPD) as an umbrella term [1] is useful in recognising the existence of distinct cough phenotypes. These might be described according to underlying pathology, for example excessive coughing associated with: airway inflammation (asthma or bronchitis); infection (respiratory tract infection, pneumonia or tuberculosis); anatomic airway distortion (lung cancer or fibrosis); mechanical irritation (acid reflux or post-nasal drip); and cough in the absence of known pathology. The analogy ends there. While COPD has clear diagnostic criteria involving objective measurement this is not the case for cough hypersensitivity syndrome.

Cough, as a clinical problem, and as currently discussed in guidelines and consensus statements, is a symptom. This is distinct from coughing reported by an observer, cough measured objectively by acoustic monitoring, or cough induced experimentally by an inhaled irritant. Indeed, not only does patient-reported chronic cough correlate poorly with cough reflex sensitivity to inhaled capsaicin or citric acid (as acknowledged by the task force [1]), it also correlates only moderately with objectively measured cough frequency [2]. Patient-reported cough improves with placebo (as in randomised controlled trials of proton pump inhibitors [1]) and behavioural training [3]. It can also improve spontaneously, despite a long duration and failed trials of treatment [4]. Explanation of these facts is currently limited.

Basic questions about cough remain unanswered. There are few descriptions of how much coughing is “normal” (and how much should be regarded as pathological). Improved understanding of cough will only come about through measurement and objective description of clinical and physiological phenomena. The objective measurement of cough frequency is of prime importance. This should be carried out in a large range of patients and respiratory conditions, as well as in healthy controls, and repeated over time, during the natural history of disease and in response to treatments. This will be made possible by agreement on how to count coughs, and the further development and increased availability of automated cough monitoring [5–7]. Objective cough counts should then be related to clinical and genetic variables [8], measures of respiratory tract inflammation (possibly including profiles of exhaled volatile organic compounds (VOCs) [9]) and neuronal and central factors [1, 10], and compared with subjective concerns and symptoms (table 1) [6, 7]. In this way cough phenotypes will be much more rigidly defined in terms of symptoms, coughing behaviour and mechanisms.

View this table:
  • View inline
  • View popup
TABLE 1

Clinical tools for measurement of cough

Many of these measurements can be employed in routine clinical practice, at least in specialist clinics, although the available tools are currently in varying stages of development. For example, automated or semi-automated cough monitors are still being refined and are currently only used in research groups [7]. An ambulatory method of measuring cough intensity is required [7]. Available standard inhalation cough challenge tests do not currently differentiate health from disease [1, 6]. Analysis of exhaled VOCs is still in its infancy [9], the cost of functional magnetic resonance imaging and genotyping may be a limiting factor, and the genetic basis of variations in cough perception and frequency has yet to be elucidated [1].

A previous ERS task force addressed the assessment of cough 8 years ago [6]. Unfortunately, there have been few advances in the tools available to measure cough since then. This is a priority for cough research. Measurement will not only allow cough hypersensitivity syndrome and other phenomena to be characterised with greater precision, it is the key to progress in this field.

Footnotes

  • Conflict of interest: None declared.

  • Received November 18, 2014.
  • Accepted December 13, 2014.
  • Copyright ©ERS 2015

References

  1. ↵
    1. Morice AH,
    2. Millqvist E,
    3. Belvisi MG, et al.
    Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J 2014; 44: 1132–1148.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Decalmer SC,
    2. Webster D,
    3. Kelsall AA, et al.
    Chronic cough: how do cough reflex sensitivity and subjective assessments correlate with objective cough counts during ambulatory monitoring? Thorax 2007; 62: 329–334.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Chamberlain S,
    2. Garrod R,
    3. Birring SS
    . Cough suppression therapy: does it work? Pulm Pharmacol Ther 2013; 26: 524–527.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Yousaf N,
    2. Montinero W,
    3. Birring SS, et al.
    The long term outcome of patients with unexplained chronic cough. Respir Med 2013; 107: 408–412.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Turner RD,
    2. Bothamley GH
    . How to count coughs? Counting by ear, the effect of visual data and the evaluation of an automated cough monitor. Respir Med 2014; 108: 1808–1815.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Morice AH,
    2. Fontana GA,
    3. Belvisi MG, et al.
    ERS guidelines on the assessment of cough. Eur Respir J 2007; 29: 1256–1276.
    OpenUrlFREE Full Text
  7. ↵
    1. Spinou A,
    2. Birring SS
    . An update on measurement and monitoring of cough: what are the important study endpoints? J Thorac Dis 2014; 6: Suppl. 7, S728–734.
    OpenUrlPubMed
  8. ↵
    1. Smit LAM,
    2. Kogevinas M,
    3. Antó JM, et al.
    Transient receptor potential genes, smoking, occupational exposures and cough in adults. Respir Res 2012; 13: 26.
    OpenUrlCrossRefPubMed
  9. ↵
    1. van de Kant KDG,
    2. van der Sande LJTM,
    3. Jöbsis Q, et al.
    Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review. Respir Res 2012; 13: 117.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Morice AH,
    2. Jakes AD,
    3. Faruqi S, et al.
    A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response. Eur Respir J 2014; 44: 1149–1155.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 45 Issue 5 Table of Contents
European Respiratory Journal: 45 (5)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cough hypersensitivity syndrome: clinical measurement is the key to progress
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Cough hypersensitivity syndrome: clinical measurement is the key to progress
Richard D. Turner, Graham H. Bothamley
European Respiratory Journal May 2015, 45 (5) 1507-1508; DOI: 10.1183/09031936.00212714

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Cough hypersensitivity syndrome: clinical measurement is the key to progress
Richard D. Turner, Graham H. Bothamley
European Respiratory Journal May 2015, 45 (5) 1507-1508; DOI: 10.1183/09031936.00212714
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory clinical practice
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Association between immunosuppressants and outcomes of COVID-19
Show more Agora

Correspondence

  • Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
  • Optimised surveillance of bronchial dysplasia in risky population
  • Reply: Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society